Allan Fletcher

Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety

Jon K. Shepherd, Savraj Grewal, Allan Fletcher et al. · Psychopharmacology · 1994 · 733 citations

Experimental Psychopathology, Behavioral Sciences, Psychiatry +14

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

Elaine A. Forster, Ian A. Cliffe, David J. Bill et al. · European Journal of Pharmacology · 1995 · 609 citations

Molecular Pharmacology, Biochemistry, Functional Selectivity +8

Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist

Allan Fletcher, Elaine A. Forster, David J. Bill et al. · Behavioural Brain Research · 1995 · 521 citations

Neurophysiology, Behavioral Neuroscience, Medicine +14

WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors

Allan Fletcher, David J. Bill, Sarah J. Bill et al. · European Journal of Pharmacology · 1993 · 220 citations

Functional Selectivity, Medicine, Synaptic Transmission +8

Evidence for a GABAergic nigrothalamic pathway in the rat

I.C. Kilpatrick, Michael S. Starr, Allan Fletcher et al. · Experimental Brain Research · 1980 · 197 citations

Neurophysiology, Neuroanatomy, Physiology +10